A Study of ELX-02 in Patients With Alport Syndrome

Condition:   Alport Syndrome Intervention:   Drug: ELX-02 Sponsor:   Eloxx Pharmaceuticals, Inc. Not yet recruiting

Source: ClinicalTrials.gov - July 7, 2022 Category: Research Source Type: clinical trials